{
  "patient_details": {
    "name": "piyush",
    "age": 30,
    "gender": "male",
    "symptoms": [
      "Hematuria",
      "Proteinuria",
      "Edema",
      "High blood pressure",
      "Flank pain",
      "Lower back pain",
      "Fatigue",
      "Changes in urine color",
      "Uremia",
      "Nausea",
      "Vomiting",
      "Loss of appetite"
    ],
    "duration": "2 years",
    "family_history": "No",
    "medications": "yes for some diseases like headache, joint pain",
    "previous_diagnoses": "no",
    "travel": "no",
    "allergies": "no",
    "other_conditions": "no"
  },
  "top_rare_diseases": [
    {
      "disease_name": "Atypical Hemolytic Uremic Syndrome (aHUS)",
      "score": 0.92,
      "description": "A rare, life-threatening disease that forms blood clots in small blood vessels throughout the body, leading to kidney failure.",
      "overview": "aHUS is characterized by microangiopathic hemolytic anemia, acute kidney injury, and thrombocytopenia.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Fatigue",
        "Changes in urine color",
        "Uremia",
        "Nausea",
        "Vomiting"
      ],
      "clinical_significance": "If untreated, aHUS can lead to end-stage renal disease and mortality.",
      "causes": "Genetic mutations (e.g., CFH, CD46, CFI), complement pathway dysregulation.",
      "related_disorders": [
        "Thrombotic Thrombocytopenic Purpura (TTP)",
        "Hemolytic Uremic Syndrome (HUS)",
        "Membranoproliferative Glomerulonephritis (MPGN)"
      ],
      "diagnosis": "Laboratory tests for hemolysis, renal function, ADAMTS13 activity, and genetic testing.",
      "treatment": "Eculizumab, plasma exchange, supportive care.",
      "clinical_trials": [
        "Investigation of Ravulizumab for adult aHUS",
        "Phase 2 study of Zilucoplan in aHUS"
      ],
      "key_aspects": [
        "Complement pathway dysregulation",
        "High mortality without treatment",
        "Chronic kidney disease progression"
      ]
    },
    {
      "disease_name": "Membranoproliferative Glomerulonephritis (MPGN)",
      "score": 0.85,
      "description": "A rare kidney disease characterized by deposits in the glomeruli, leading to inflammation and kidney damage.",
      "overview": "MPGN affects the glomeruli, causing proteinuria and hematuria, often progressing to chronic kidney disease.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Flank pain",
        "Lower back pain",
        "Fatigue",
        "Changes in urine color"
      ],
      "clinical_significance": "Can lead to end-stage renal disease if untreated.",
      "causes": "Infections, autoimmune diseases, genetic factors, chronic diseases.",
      "related_disorders": [
        "Lupus Nephritis",
        "Chronic Hepatitis B or C",
        "Cryoglobulinemia",
        "SLE-associated nephritis"
      ],
      "diagnosis": "Kidney biopsy, urinalysis, blood tests for infections or autoimmune markers.",
      "treatment": "Immunosuppressants, antivirals, ACE inhibitors.",
      "clinical_trials": [
        "Study of Rituximab in MPGN",
        "Investigation of new biologics for MPGN"
      ],
      "key_aspects": [
        "Glomerular deposition of immune complexes",
        "Progressive kidney damage",
        "Variable etiology"
      ]
    },
    {
      "disease_name": "Alport Syndrome",
      "score": 0.78,
      "description": "A genetic disorder affecting the type IV collagen in the kidneys, leading to chronic kidney disease.",
      "overview": "Characterized by hematuria, hearing loss, and eye abnormalities, progressing to kidney failure.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Flank pain",
        "Lower back pain",
        "Changes in urine color"
      ],
      "clinical_significance": "Progressive kidney disease often leading to end-stage renal disease.",
      "causes": "Mutations in COL4A3, COL4A4, or COL4A5 genes.",
      "related_disorders": [
        "Thin Basement Membrane Nephropathy",
        "Focal Segmental Glomerulosclerosis (FSGS)",
        "Other collagen-related disorders"
      ],
      "diagnosis": "Family history, audiology tests, genetic testing, kidney biopsy.",
      "treatment": "ACE inhibitors, dietary modifications, transplantation.",
      "clinical_trials": [
        "Study of anti-fibrotic agents in Alport",
        "Gene therapy trials for Alport"
      ],
      "key_aspects": [
        "Genetic mutation in type IV collagen",
        "Progressive kidney failure",
        "Sensorineural hearing loss association"
      ]
    },
    {
      "disease_name": "Goodpasture's Syndrome",
      "score": 0.75,
      "description": "An autoimmune disease attacking the lungs and kidneys, leading to bleeding and kidney inflammation.",
      "overview": "Characterized by anti-GBM antibodies causing glomerulonephritis and pulmonary hemorrhage.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Flank pain",
        "Lower back pain",
        "Coughing up blood",
        "Fatigue"
      ],
      "clinical_significance": "Rapid progression to kidney failure and severe lung issues.",
      "causes": "Autoantibodies against glomerular and alveolar basement membranes.",
      "related_disorders": [
        "Anti-GBM Disease",
        "Wegener's Granulomatosis",
        "Pulmonary Vasculitis"
      ],
      "diagnosis": "Anti-GBM antibody tests, chest X-ray, urine analysis.",
      "treatment": "Plasmapheresis, immunosuppressants, supportive care.",
      "clinical_trials": [
        "Investigation of new immunosuppressive regimens",
        "Plasmapheresis techniques improvement"
      ],
      "key_aspects": [
        "Autoantibody-mediated damage",
        "Rapid kidney and lung involvement",
        "Aggressive treatment required"
      ]
    },
    {
      "disease_name": "Fabry Disease",
      "score": 0.7,
      "description": "A rare genetic disorder causing the buildup of a particular type of fat in the body's cells.",
      "overview": "Leads to pain, kidney failure, heart issues, and nervous system involvement.",
      "signs_symptoms": [
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Flank pain",
        "Lower back pain",
        "Fatigue",
        "Changes in urine color",
        "Nausea",
        "Vomiting",
        "Gastrointestinal issues"
      ],
      "clinical_significance": "Progressive organ damage, especially kidneys, heart, and nerves.",
      "causes": "Deficiency of alpha-Gal A enzyme due to GLA gene mutation.",
      "related_disorders": [
        "Gaucher Disease",
        "Niemann-Pick Disease",
        "Other lysosomal storage diseases"
      ],
      "diagnosis": "Enzyme activity assay, genetic testing, clinical evaluation.",
      "treatment": "Enzyme Replacement Therapy (ERT), supportive care.",
      "clinical_trials": [
        "Study of pharmacological chaperones",
        "Gene therapy for Fabry Disease"
      ],
      "key_aspects": [
        "Lysosomal storage disorder",
        "Multi-system involvement",
        "Symptoms in early age but can present later"
      ]
    }
  ]
}